Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 100 /hr
Hire Dr Brijesh P.
United States
USD 100 /hr
Expert Formulation Scientist with 12+ years of experience in developing pharma OTC & personal care products
Profile Summary
Subject Matter Expertise
Services
Writing
Technical Writing
Research
Market Research,
Feasibility Study,
Systematic Literature Review
Consulting
Business Strategy Consulting,
Healthcare Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Statistical Analysis
Product Development
Formulation,
Recipe Development,
Deformulation,
Stability/Shelf Life Testing,
Product Evaluation,
Manufacturing,
Concept Development,
Prototyping
Work Experience
Director R&D
ABC
January 2023 - January 2023
Education
PhD (Department of Pharmaceutical Sciences)
Texas Tech University Health Sciences Center
2009 - 2014 ![]()
Masters in Industrial Pharmacy (Pharmaceutical Sciences)
Campbell University
2007 - 2009 ![]()
B. Pharm. (Pharmacy)
BMCPER
2002 - 2006 ![]()
Certifications
Publications
JOURNAL ARTICLE
Rashid, J., Patel, B., Nozik-Grayck, E., McMurtry, I.F., Stenmark, K.R., Ahsan, F.(2017). Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH) . Journal of Controlled Release. 250. p. 96-106.
Patel, B., Rashid, J., Ahsan, F.(2017). Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs . European Journal of Pharmaceutical Sciences. 96. p. 560-570.
Patel, B., Rashid, J., Gupta, N., Ahsan, F.(2017). Low-Molecular-Weight Heparin-Coated and Montelukast-Filled Inhalable Particles: A Dual-Drug Delivery System for Combination Therapy in Asthma . Journal of Pharmaceutical Sciences. 106. (4). p. 1124-1135.
Gupta, N., Al-Saikhan, F.I., Patel, B., Rashid, J., Ahsan, F.(2015). Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs . International Journal of Pharmaceutics. 488. (1-2). p. 33-43.
Patel, B., Gupta, N., Ahsan, F.(2015). Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome . European Journal of Pharmaceutics and Biopharmaceutics. 89. p. 163-174.
Gupta, N., Patel, B., Nahar, K., Ahsan, F.(2014). Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats . European Journal of Pharmaceutics and Biopharmaceutics. 88. (3). p. 1046-1055.
Patel, B., Gupta, N., Ahsan, F.(2014). Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of Asthma . Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27. (1). p. 12-20.
Gupta, N., Patel, B., Ahsan, F.(2014). Nano-engineered erythrocyte ghosts as inhalational carriers for delivery of fasudil: Preparation and characterization . Pharmaceutical Research. 31. (6). p. 1553-1565.
Patel, B., Gupta, N., Ahsan, F.(2014). Aerosolized montelukast polymeric particles - An alternative to oral montelukast-alleviate symptoms of asthma in a rodent model . Pharmaceutical Research. 31. (11). p. 3095-3105.
Nahar, K., Absar, S., Patel, B., Ahsan, F.(2014). Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature . International Journal of Pharmaceutics. 464. (1-2). p. 185-195.
Nahar, K., Gupta, N., Gauvin, R., Absar, S., Patel, B., Gupta, V., Khademhosseini, A., Ahsan, F.(2013). In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals . European Journal of Pharmaceutical Sciences. 49. (5). p. 805-818.
Patel, B., Gauvin, R., Absar, S., Gupta, V., Gupta, N., Nahar, K., Khademhosseini, A., Ahsan, F.(2012). Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models . American Journal of Physiology - Lung Cellular and Molecular Physiology. 303. (9).
Patel, B., Gupta, V., Ahsan, F.(2012). PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin . Journal of Controlled Release. 162. (2). p. 310-320.